Support in USA : 1-978- 707-9553 / Support in India : +91- 9987711567

  • Apple Pharmaceuticals

Instgra - Tafero-EM - 3 Month Course

Dolutegravir-Emtricitabine Tenofovir Alafenamide

Availability: In stock

Special Price $ 250

BRAND : Instgra - Tafero-EM
STRENGTH : 50mg, 25mg and 200mg
INGREDIENT : Dolutegravir-Emtricitabine Tenofovir Alafenamide
COMPANY NAME : Hetero
COUNT : 30 Tablets



Description of Instgra - Tafero-EM - 3 Month Course

Instgra - Tafero-EM - 3 Month Course

Description : Tafero-EM is a recently launched drug for the treatment of HIV and hepatitis B. The taboo-EM tablet contains the active ingredients Emtricitabine (Emtricitabine) 200 mg and Tenofovir Alafenamide (Tenofovir Alafenamide) 25 mg, which helps stop the growth of the HBV and hiv virus in the blood. Instgra tablet is used to treat HIV infection. It is an FDA approved drug that reduces the amount of HIV in the body. Instgra is an HIV-1 antiviral agent and inhibits the HIV-infection integrase inhibitor.

Pharmacology of Instgra - Tafero-EM - 3 Month Course

Indication of Instgra - Tafero-EM - 3 Month Course

Dose & Dosage's of Instgra - Tafero-EM - 3 Month Course

Side Effects of Instgra - Tafero-EM - 3 Month Course

Contraindication of Instgra - Tafero-EM - 3 Month Course

Drug Interaction of Instgra - Tafero-EM - 3 Month Course

Precaution of Instgra - Tafero-EM - 3 Month Course

Usage & Safety profile of Instgra - Tafero-EM - 3 Month Course Pregnancy & Lactation

Storage of Instgra - Tafero-EM - 3 Month Course